EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence

Valeria D'Argenio iD, Rossella Tomaiuolo, Silvia Bargeri iD, Giulia Sancesario iD

Genes · 12.02.2026 · 17 (2) · 233

DOI: 10.3390/genes17020233 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 12.02.2026. Verfasst von Valeria D'Argenio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Sciences and Quality of Life Promotion, San Raffaele Open University, Via di Val Cannuta 247, 00166 Rome, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Artificial Intelligence, Genomics, Precision Medicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente anno 2025, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) represents a critical global health challenge, with its prevalence and associated costs expected to double significantly by 2030 and 2050. While lifestyle interventions are crucial, sporadic late-onset AD has a substantial genetic component (40–80% heritability), though known variants limit the scope of traditional precision medicine. Crucially, sex and gender are significant risk determinants, with women accounting for two-thirds of cases due to a complex interplay of biological and sociocultural factors. This review focuses on the influence of genetic and gender-related factors, examining large-scale genome-wide association studies (GWASs) and their role in developing advanced genetic risk scores (GRS) for precision genomics. We also explore the potential of Artificial Intelligence (AI) for multimodal big data analysis and digital health tools to promote personalized prevention and emerging concerns about ethics, privacy and data treatment. The convergence of these findings underscores the urgent need for a genetic-, sex- and gender-informed precision-medicine approach to AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseArtificial IntelligenceGenomicsPrecision MedicineHumansGenome-Wide Association StudyFemaleDigital HealthGenetic Risk ScoreGenetic Predisposition to DiseaseMale

Stichwörter der Autor:innen

Alzheimer’s DiseaseGWASartificial intelligencedata treatmentdigital healthethicsgenderneurogenomics

Autor:innen und Institutionen

  • Department of Human Sciences and Quality of Life Promotion, San Raffaele Open University, Via di Val Cannuta 247, 00166 Rome, Italy.
  • CEINGE-Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore 486, 80145 Naples, Italy.
  • Università Vita-Salute San Raffaele, 20123 Milan, Italy.
  • IRCCS Galeazzi Sant'Ambrogio, 20157 Milan, Italy.
  • Unit of Clinical Epidemiology, IRCCS Istituto Ortopedico Galeazzi, 20157 Milan, Italy.
  • Biobank and Clinical Neurochemistry, IRCCS Santa Lucia Foundation, 00179 Rome, Italy.

ORCID-Profile: Valeria D'Argenio, Silvia Bargeri, Giulia Sancesario

Förderung

  • Ricerca Corrente anno 2025, Ministero della Salute

Zitieren

APA

D'Argenio, V., Tomaiuolo, R., Bargeri, S., & Sancesario, G. (2026). Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence. Genes, 17(2), 233. https://doi.org/10.3390/genes17020233

Vancouver

D'Argenio V, Tomaiuolo R, Bargeri S, Sancesario G. Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence. Genes. 2026;17(2):233. doi:10.3390/genes17020233

BibTeX
@article{DArgenio2026,
  author = {D'Argenio, Valeria and Tomaiuolo, Rossella and Bargeri, Silvia and Sancesario, Giulia},
  title = {Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {233},
  doi = {10.3390/genes17020233}
}
Kostenlos starten →